ライフサイエンスコーパス: angiography

1 t manifestation of CAV diagnosed by coronary angiography.

2 rred for evaluation of suspected PAD with CT angiography.

3 compared with the gold standard CT pulmonary angiography.

4 a pulmonary embolism visible on CT pulmonary angiography.

5 osis was assessed using computed tomographic angiography.

6 at coronary CTA and at conventional coronary angiography.

7 l diagnostic testing than triple-rule-out CT angiography.

8 eral filling, as determined by multiphase CT angiography.

9 ural network to detect LVOs at multiphase CT angiography.

10 CTA were referred for conventional coronary angiography.

11 l regions using optical coherence tomography angiography.

12 in patients with aSAH on computed tomography angiography.

13 lar permeability was analyzed by fluorescein angiography.

14 indication to undergo a computed tomography-angiography.

15 phase 2; and late venous, phase 3) of the CT angiography.

16 ral perfusion during interventional cerebral angiography.

17 r randomization and prasugrel after coronary angiography.

18 ) optical coherence tomography (OCT) and OCT angiography.

19 neovascularization at week 12 on fluorescein angiography.

20 e patients were randomized to early coronary angiography.

21 perfusion lung scanning or formal pulmonary angiography.

22 occurred in 18% of cases (surgery (82%) and angiography (11%) alone).

23 , 179 underwent coronary computed tomography angiography 18 months post-surgery showing 24% graft occ

24 lower between those who either underwent CT angiography (2.0% compared with 4.7%; p = 0.0017) or end

25 n 3827 patients who were undergoing coronary angiography, 250 who were undergoing cardiac surgery, an

26 t group, was less likely to undergo coronary angiography (3.4% versus 10.2%, P<0.0001), have high-gra

27 (55%) than with coronary triple-rule-out CT angiography (47%) (P = .23).

28 ography (78.3% versus 81.4%), early coronary angiography (49.2% versus 54.1%), percutaneous coronary

29 35.7%), and received less-frequent coronary angiography (78.3% versus 81.4%), early coronary angiogr

30 Fluorescein angiography, a combination of 2 OCT protocols, and multi

31 y, ventilation/perfusion scanning, pulmonary angiography, a combination of these tests, or PE signs a

32 Single-phase CT angiography achieved an AUC of 0.74 (95% confidence inte

33 irus disease 2019, 40 underwent CT pulmonary angiography after a median of 7 days (4-8 d) since ICU a

34 The benefit of emergency coronary angiography after resuscitation from out-of-hospital car

35 but the addition of CT perfusion imaging and angiography allows a positive diagnosis of ischaemic str

36 rtile range, 4-9.1) years with 4710 coronary angiographies analyzed.

37 rd deviation]; seven women) who underwent CT angiography and 32 propensity score-matched control pati

38 ium scoring, with repeat computed tomography angiography and calcium scoring at one year.

39 ional two-dimensional readout of CT coronary angiography and cardiac MRI resulted in eight of 17 case

40 rwent (18)F-fluoride PET-computed tomography angiography and computed tomography calcium scoring, wit

41 s with CKD underwent ferumoxytol-enhanced MR angiography and duplex US.

42 Fluorescein angiography and fundus autofluorescence were useful in d

43 nd high-throughput metabolic profiles in the Angiography and Genes Study (ANGES).

44 ence in health benefits compared with the CT angiography and immediate thrombectomy strategy was 0.39

45 ified by the 2019 Society for Cardiovascular Angiography and Interventions (SCAI) shock stages using

46 recently proposed Society for Cardiovascular Angiography and Interventions (SCAI) stages as an approa

47 on of MI; and the Society for Cardiovascular Angiography and Interventions (SCAI).

48 for LVO (n = 270) were confirmed by catheter angiography and LVO-negative examinations (n = 270) were

49 ts enrolled in BIOSOLVE-II undergoing serial angiography and optical coherence tomography (post-inter

50 cedurally in patients who underwent coronary angiography and patients who underwent cardiac surgery a

51 s were observed in 2.5% and 2.1% of coronary angiography and percutaneous coronary intervention proce

52 as performed in patients undergoing coronary angiography and possible percutaneous coronary intervent

53 ial invasive strategy consisting of coronary angiography and revascularization (if appropriate) added

54 death or myocardial infarction with initial angiography and revascularization plus guideline-based m

55 re ischemia to an initial invasive strategy (angiography and revascularization when feasible) and med

56 te the efficacy and safety of early coronary angiography and to determine the prevalence of acute cor

57 e infarct-related artery at initial coronary angiography, and complete (>=70%) ST-segment resolution

58 fied prespecified imaging evaluation (CT, CT angiography, and CTP with Rapid Processing of Perfusion

59 phy, OCT, OCT angiography, indocyanine green angiography, and fluorescein angiography for comparison

60 , fluorescein angiography, indocyanine green angiography, and fundus autofluorescence.

61 ry artery calcium (CAC) scoring, coronary CT angiography, and MRI of the carotid arteries.

62 mages (color fundus photography, fluorescein angiography, and OCT) for all investigator-determined ca

63 uch as echocardiography and cardiac CT or CT angiography are the first-line modalities for clinically

64 l diagnostic cut-offs for CAV, with coronary angiography as gold standard, were defined using receive

65 pportive evidence for the use of coronary CT angiography as the first-line test for the evaluation of

66 re eligible if they underwent a CT pulmonary angiography, as part of the routine management in case o

67 =209) underwent coronary computed tomography angiography at baseline and 1-year to assess changes in

68 62-patient cohort who underwent CT pulmonary angiography before the first reported local COVID-19 cas

69 m to analyze patients who underwent coronary angiography between January 1, 2009, and September 30, 2

70 tive for COVID-19 who underwent CT pulmonary angiography between March 13 and April 5, 2020.

71 Fluorescein angiography can be an important tool in evaluating pedia

72 hods including contrast material-enhanced MR angiography, carotid plaque imaging, and arterial spin l

73 hy verified bone-removal computed tomography angiography cases.

74 ase (CAD) using coronary computed tomography angiography (CCTA) has seen a paradigm shift in the last

75 low-attenuation plaque burden on coronary CT angiography (CCTA) might be a better predictor of the fu

76 ents undergoing coronary computed tomography-angiography (CCTA).

77 clinical utility of ferumoxytol-enhanced MR angiography compared with duplex US for vascular mapping

78 raphy (QCA) but computed tomography coronary angiography could exclude significant CAD.

79 R) relies on manual review of multi-slice CT angiography (CTA) by physicians which is a tedious and t

80 Using computed tomography angiography (CTA) data from 258 AAA patients, the lumen

81 se using serial coronary computed tomography angiography (CTA) is of clinical interest.

82 was to test if coronary computed tomography angiography (CTA) may be used to exclude coronary artery

83 It is best demonstrated and diagnosed on CT angiography (CTA) of the neck because of its ability to

84 l between 1990 and 2016 who had available CT angiography (CTA) or digital subtraction angiography (DS

85 al morphological parameters obtained from CT-angiography (CTA) or digital subtraction angiography (DS

86 ned as when single phase computed tomography angiography (CTA) revealed a gradual decline in contrast

87 Computed Tomography Angiography (CTA) scans of 20 trauma TEVAR patients (17

88 regadenoson and coronary computed tomography angiography (CTA) to rule out cardiac allograft vasculop

89 ent of patients for whom computed tomography angiography (CTA) was requested from the emergency depar

90 had undergone coronary computed tomographic angiography (CTA).

91 andard-protocol invasive FFR and coronary CT angiography (CTA).

92 ess testing (n=4533) or computed tomographic angiography (CTA; n=4677).

93 sis on baseline computed tomography coronary angiography (CTCA) performed for suspected coronary arte

94 have examined computed tomographic pulmonary angiography (CTPA) rates in subgroups at high risk for a

95 r increased motion artifacts on CT pulmonary angiography (CTPA).

96 AI-based CT FFR from triple-rule-out CT angiography data sets was retrospectively obtained in 15

97 ticipants were screened from a normative OCT angiography database.

98 id removal during spinal digital subtraction angiography decreased participants' radiation exposure w

99 f dual energy computed tomographic pulmonary angiography (DECTPA) in revealing vasculopathy in corona

100 CT FFR and triple-rule-out CT angiography demonstrated agreement in severity of corona

101 OCT angiography demonstrated early emergence of peripapillar

102 Fluorescein angiography demonstrated peripheral retinal ischemia.

103 stress perfusion cardiac MRI and coronary CT angiography-derived fractional flow reserve from real-wo

104 Background Spinal digital subtraction angiography (DSA) exposes patients and operators to subs

105 CT-angiography (CTA) or digital subtraction angiography (DSA) from 207 patients with BTAs and a cont

106 With Digital Subtraction Angiography (DSA) perfusion analysis, we are able to ide

107 Digital subtraction angiography (DSA) tubogram revealed rupture and separati

108 CT angiography (CTA) or digital subtraction angiography (DSA) were evaluated.

109 ether CA-AKI mediates the association of pre-angiography estimated glomerular filtration rate with ad

110 does not mediate the association of the pre-angiography estimated glomerular filtration rate with th

111 was not a mediator of the association of pre-angiography estimated glomerular filtration rate with th

112 ospective study evaluated 540 adults with CT angiography examinations for suspected acute ischemic st

113 d an increase in positive lower-extremity CT angiography examinations in patients who presented with

114 Preprocessing of the CT angiography examinations included vasculature segmentati

115 ced by using delayed phases at multiphase CT angiography examinations.

116 from subjects with same-day UWF fluorescein angiography (FA) and color imaging were evaluated.

117 Fluorescein angiography (FA) and SS-OCTA imaging (PLEX Elite 9000, C

118 were imaged longitudinally with fluorescein angiography (FA) and swept-source (SS) OCT angiography (

119 pared with ultra-widefield (UWF) fluorescein angiography (FA) imaging to better understand changes in

120 Fluorescein angiography (FA) is a procedure used to image the vascul

121 Fluorescein angiography (FA) showed very severe leakage at the junct

122 Ultra-widefield fluorescein angiography (FA) was also performed when clinically indi

123 Fluorescein angiography (FA) was performed in 113 eyes, of which 59

124 ical coherence tomography (OCT), fluorescein angiography (FA), blue fundus autofluorescence (BFAF), e

125 graphy angiography (SS-OCTA) and fluorescein angiography (FA).

126 ere established as affirmed with fluorescein angiography (FA).

127 patients with nAMD confirmed on fluorescein angiography (FA).

128 OCT angiography features associated with exudation include a

129 ex, and duplex US or ferumoxytol-enhanced MR angiography findings as independent variables.

130 In 1 patient imaged with fluorescein angiography, focal segments of retinal venulitis were de

131 nger patients ($68 950 difference between CT angiography followed by immediate thrombectomy and no va

132 Results Base-case calculation showed that CT angiography followed by immediate thrombectomy had the l

133 O after intravenous thrombolysis, and (c) CT angiography for all and best medical management (includi

134 imaging and best medical management, (b) CT angiography for all patients and immediate thrombectomy

135 ical trials, does not support early coronary angiography for comatose survivors of cardiac arrest wit

136 docyanine green angiography, and fluorescein angiography for comparison with the pathologic maculae.

137 Patients who had undergone 4D CT angiography for the suspicion of acute ischemic stroke w

138 of patients also underwent indocyanine green angiography, fundus fluorescein angiography, mesopic mic

139 (<= 0.80) and stenosis at triple-rule-out CT angiography (>= 50%), as well as downstream cardiac diag

140 el Disease After Early PCI for STEMI) trial, angiography-guided percutaneous coronary intervention (P

141 D-dimers on the day of CT pulmonary angiography had a predictive accuracy of 0.90 (95% CIs:

142 atient with negative results at CT pulmonary angiography had deep venous thrombosis, thus resulting i

143 of 14% of patients undergoing early coronary angiography having an acutely occluded culprit coronary

144 safety of intra-arterial computed tomography angiography (IA-CTA) with ultra-low-volume iodine contra

145 ) or standard (48 to 72 h) invasive coronary angiography (ICA).

146 sing ultra-widefield (UWF) indocyanine green angiography (ICGA).

147 oidal hyperpermeability on indocyanine green angiography (ICGA).

148 cs, clinical features, and indocyanine green angiography (ICGA).

149 vative strategy of medical therapy alone and angiography if medical therapy failed.

150 racranial and cervicocranial arteries, by CT angiography if MR angiography was contraindicated, and b

151 zed color fundus photography and fluorescein angiography image data.

152 OCT angiography images centered at the fovea were obtained o

153 to achieve this aim, the cranio-cervical CT angiography images of patients who were referred to our

154 is vascular anatomy using magnetic resonance angiography images.

155 based on optical coherence tomography (OCT) angiography imaging and deep learning.

156 onary plaque by coronary computed tomography angiography in 258 previously preeclamptic women aged 40

157 current role of coronary computed tomography angiography in acute chest pain presentations.

158 Screening for large-vessel occlusion with CT angiography in patients with acute minor stroke is cost-

159 The cost-effectiveness of CT angiography in patients with minor stroke (National Inst

160 Purpose To evaluate cost-effectiveness of CT angiography in the detection of large-vessel occlusion (

161 supplanted by computed tomographic pulmonary angiography in the diagnostic approach to acute pulmonar

162 pivotal role of coronary computed tomography angiography in the workup of stable chest pain in patien

163 oronary angiography versus no early coronary angiography in this multicenter study.

164 , assessed with coronary computed tomography angiography, in all patients that had primary outcome im

165 ble chest pain, coronary computed tomography angiography increases the sensitivity for coronary arter

166 Ferumoxytol-enhanced MR angiography independently predicted AVF success in model

167 ere imaged with fundus photography, OCT, OCT angiography, indocyanine green angiography, and fluoresc

168 h as enhanced depth imaging-OCT, fluorescein angiography, indocyanine green angiography, and fundus a

169 d with autofluorescence imaging, fluorescein angiography, indocyanine green angiography, or a combina

170 was calculated from dual-energy CT pulmonary angiography iodine images.

171 CT angiography is highly sensitive in the characterization

172 However, CT angiography is less sensitive in detecting intranidal an

173 Computed tomography angiography is recommended as the standard diagnosis too

174 Traditional digital subtraction angiography is still regarded as the gold standard in th

175 ure assessed by coronary computed tomography angiography, is associated with increased risk of future

176 dence of coronary artery disease on coronary angiography managed with either percutaneous coronary in

177 OCT angiography measurements correlated with both radiation

178 yanine green angiography, fundus fluorescein angiography, mesopic microperimetry, and multifocal elec

179 Combining these dual-energy CT pulmonary angiography metrics with main pulmonary artery size and

180 30 and 60 years, that had magnetic resonance angiography (MRA) during the period 2016-2018.

181 s, including 3-dimensional time-of-flight MR angiography, MRI navigators, and a T1-weighted MRI scan.

182 and 6432 ng/mL d-dimer units in CT pulmonary angiography-negative and CT pulmonary angiography-positi

183 with troponin elevation and normal coronary angiography) occurred in 15% of patients with DSP and we

184 Optical coherence tomography angiography (OCT-A) allows noninvasive visualization of

185 Recently, optical coherence tomography angiography (OCT-A) emerged as a non-invasive imaging te

186 utofluorescence (BFAF), en face OCT, and OCT angiography (OCT-A) was included in the study.

187 l optical coherence tomography (OCT) and OCT-angiography (OCT-A), were performed at baseline and foll

188 ative AMD using optical coherence tomography angiography (OCT-A).

189 (n = 22) using optical coherence tomography angiography (OCT-A).

190 Angiography, OCT, and CMR were evaluated at blinded, ind

191 Optical coherence tomography angiography (OCTA) allows for noninvasive imaging of the

192 n (SSPiM) using optical coherence tomography angiography (OCTA) among branch retinal vein occlusion d

193 n NE-MNV identified on swept-source (SS) OCT angiography (OCTA) and the "double-layer sign" on struct

194 tion (SSPiM) in optical coherence tomography angiography (OCTA) and treatment response in diabetic ma

195 udies that used optical coherence tomography angiography (OCTA) as a primary diagnostic tool to evalu

196 n angiography (FA) and swept-source (SS) OCT angiography (OCTA) before and after panretinal photocoag

197 giography (SSADA) software 7.1 to obtain OCT angiography (OCTA) images from fovea-centered 3 x 3-mm(2

198 mm swept-source optical coherence tomography angiography (OCTA) images of 1 eye of consecutive early

199 ysis of retinal optical coherence tomography angiography (OCTA) images, but the repeatability of metr

200 oiditis (SC) by Optical Coherence Tomography Angiography (OCTA) in a multimodal imaging approach.

201 jects underwent optical coherence tomography angiography (OCTA) scans centered on the fovea and tempo

202 raphy (OCT) and optical coherence tomography angiography (OCTA) were performed at baseline and at eac

203 Optical coherence tomography (OCT) and OCT angiography (OCTA) were performed, and data on age, sex,

204 ence tomography (OCT) technology, called OCT angiography (OCTA), capable of visualizing retina vascul

205 If CNV was detected by OCT angiography (OCTA), its location and dimension were spat

206 recruited prospectively and imaged with OCT angiography (OCTA).

207 pillary plexus (DCP) were assessed using OCT angiography (OCTA).

208 asurement, CFP, spectral-domain OCT, and OCT angiography (OCTA).

209 sis of 50% and greater at triple-rule-out CT angiography (odds ratio, 3.4; 95% confidence interval: 1

210 -examinations (unenhanced-chest CT [TNC], CT-angiography of chest and abdomen [CTA-Chest, CTA-Abdomen

211 MRI of the brain was performed along with MR angiography of the brain.

212 Imaging was by MR angiography of the intracranial and cervicocranial arter

213 ty was 2.8% in the FFR group and 5.9% in the angiography-only group (p < 0.0001).

214 er risk of mortality at 1 year compared with angiography-only revascularization (hazard ratio: 0.57;

215 , fluorescein angiography, indocyanine green angiography, or a combination thereof.

216 cant improvement relative to single-phase CT angiography (P = .01).

217 r than that of CTA and quantitative coronary angiography (P=0.01 and P<0.001, respectively).

218 rtheast were less likely to receive coronary angiography, percutaneous coronary intervention, and mec

219 luded in-hospital mortality, use of coronary angiography, percutaneous coronary intervention, mechani

220 Use of coronary angiography, percutaneous coronary intervention, mechani

221 of VSP was assessed with computed tomography angiography/perfusion imaging and clinical examination.

222 monary angiography-negative and CT pulmonary angiography-positive subgroups, respectively (P < .001).

223 The relative rate of CT pulmonary angiography positivity was recorded.

224 is provided by digital subtraction pulmonary angiography, preferably performed at a center familiar w

225 fluorescence on late-phase indocyanine green angiography, prompted genetic testing which revealed the

226 OCT angiography provided a quantitative measurement of retin

227 two domains (i.e. funduscopy and fluorescein angiography) provides an unrivaled way for the translati

228 A contrast material-enhanced CT angiography pulmonary embolism protocol and cardiac MRI

229 CAD was defined by quantitative coronary angiography (QCA) but computed tomography coronary angio

230 s severity measured by quantitative coronary angiography (QCA) on the benefit of complete revasculari

231 ial signal bands, and with optical coherence angiography, quantifying retinal perfusion at the microc

232 tegy consisting of medical therapy alone and angiography reserved for those in whom medical therapy h

233 asculature stenoses, ferumoxytol-enhanced MR angiography resulted in characterization of 88 of 236 (3

234 n angiography results, and indocyanine green angiography results were collected.

235 escence results, ultra-widefield fluorescein angiography results, and indocyanine green angiography r

236 ual acuity, spectral-domain OCT results, OCT angiography results, fundus autofluorescence results, ul

237 If invasive coronary angiography revealed <50% stenosis in all major arteries

238 Early coronary angiography revealed a culprit vessel in 47%, with a tot

239 Indocyanine green angiography revealed chroidal vascular dilatations in bo

240 Fluorescein angiography revealed delayed retinal arterial filling, r

241 Indocyanine green angiography revealed dilated hyperpermeable choroidal va

242 Indocyanine green and OCT angiography revealed numerous additional subclinical cho

243 pathologic features, ferumoxytol-enhanced MR angiography revealed peripheral arterial disease not rec

244 CT coronary angiography revealed significant stenoses in seven of 17

245 rom volumetric Computed Tomography Pulmonary Angiography scans and clinical patient data from the EMR

246 gators and a 3-dimensional time-of-flight MR angiography sequence.

247 Fluorescein angiography showed bilateral dilated, ectatic capillarie

248 Ferumoxytol-enhanced MR angiography showed excellent inter- and intrareader repe

249 ing of the arteriolar vessel wall whilst OCT angiography showed extreme corkscrew course of arteriole

250 Fluorescein angiography showed no definite leakage in any involved e

251 Fluorescein angiography showed saccular lesions that filled slowly d

252 Optical coherence tomography angiography shows some associations with disease severit

253 D loss was associated with lower OCT and OCT-angiography signal strength (odds ratio [95% confidence

254 ng swept-source optical coherence tomography angiography (SS-OCTA) and fluorescein angiography (FA).

255 pt-source optical coherence tomography based angiography (SS-OCTA) macular volume scans (3 x 3 mm and

256 h swept-source optical coherence tomographic angiography (SS-OCTA) was performed, and the percentage

257 ng swept-source optical coherence tomography angiography (SS-OCTA), and its relationship with the cen

258 with split-spectrum amplitude-decorrelation angiography (SSADA) software 7.1 to obtain OCT angiograp

259 Key coronary CT angiography studies have included rigorous meta-analysis

260 ly safe and effective on a single or biplane angiography system despite increased contrast load and f

261 oronary physiology as an adjunct to coronary angiography to guide percutaneous coronary interventions

262 nt, rendering computed tomographic pulmonary angiography to rule out PE unnecessary in 39%.

263 We used retinal angiography to study blood-retinal barrier integrity.

264 d monitoring consisting of repeated coronary angiographies together with systematic assessments of cl

265 ention of Serious Adverse Outcomes Following Angiography) trial with comprehensive baseline and outco

266 s in 34 patients undergoing renal or cardiac angiography under baseline conditions and during hyperem

267 maging including pseudocolor and fluorescein angiography using an Optos 200Tx device.

268 Ultra-widefield fluorescein angiography (UWFA; California Optos [Optos, Dunfermline,

269 rmal findings on ultra-widefield fluorescein angiography (UWFFA) and OCT.

270 The use of computed tomography pulmonary angiography varied between 13.3% and 98.3% across the co

271 ities included computed tomography pulmonary angiography, ventilation/perfusion scanning, pulmonary a

272 d model trained on 1,177 digital subtraction angiography verified bone-removal computed tomography an

273 formed consent regulations to early coronary angiography versus no early coronary angiography in this

274 Upon comparison with indocyanine green angiography videoangiography (ICG-VA) imaging, also oper

275 CT FFR derived from triple-rule-out CT angiography was a better predictor for coronary revascul

276 icocranial arteries, by CT angiography if MR angiography was contraindicated, and by transcranial Dop

277 cranial Doppler and carotid ultrasound if CT angiography was contraindicated.

278 CT angiography was cost-effective when the probability of L

279 The net monetary benefit of performing CT angiography was higher in younger patients ($68 950 diff

280 Fluorescein angiography was not found to be associated directly with

281 CT pulmonary angiography was performed 19.8 days +/- 6.1 (95% CI: 18.

282 When angiography was performed, women had a lower proportion

283 3+/-17 years), computed tomography pulmonary angiography was the dominant modality of diagnosis in al

284 However, computed tomography pulmonary angiography was the dominant modality of diagnosis, even

285 Using high-resolution 7 T time-of-flight angiography we manually classified hippocampal vasculari

286 Using optical coherence tomography angiography, we measured the cochlear blood flow of sals

287 o >=0.9 as documented by computer tomography angiography were eligible for enrollment.

288 tion and dual-phase dual-energy CT pulmonary angiography were included between 2012 and 2014.

289 suspected TIA/minor stroke and non-invasive angiography were included.

290 , near-infrared reflectance, and fluorescein angiography were investigated.

291 ckness and fluorescein and indocyanine green angiography were no different in the 2 eras.

292 , 4622 diabetic patients undergoing coronary angiography were screened for inclusion.

293 ld swept source optical coherence tomography angiography (WF SS-OCTA) imaging was compared with ultra

294 dy, 35 consecutive patients who underwent MR angiography with 4D flow MRI at 3.0 T from December 2017

295 Fluorescence angiography with ICG allows intraoperative quantitative

296 Fluorescence angiography with ICG can serve as an intraoperative qual

297 was performed by near-infrared fluorescence angiography with ICG; a software was used for quantitati

298 es, including widefield imaging, fluorescein angiography (with peripheral sweeps), and OCT.

299 reference standard was quantitative invasive angiography, with at least 50% stenosis in at least 1 co

300 CGs of adult patients who underwent coronary angiography within 24 h from each ECG were used for deve